Introducing Richard Tame, a seasoned executive currently serving as CFO at Coeus Institute. His journey across various industries and renowned corporations has been nothing short of remarkable. From his early days at British Airways to his stints at tech giants like Amazon, Meta, and Lyft, Richard's career has been marked by a wealth of diverse experiences.

Dr. Seth Lederman, CEO and Chairman of Tonix Pharmaceuticals, shares insights into his journey from medical practice to pharmaceutical entrepreneurship. From his early days combating the AIDS epidemic to specializing in rheumatology and fibromyalgia research, Dr. Lederman discusses the lessons learned from founding and leading Tonix Pharmaceuticals.

Hadi Chaudhry is the CEO & President at CareCloud, a publicly traded healthcare technology company. Hadi was an early employee at CareCloud where he rose the ranks helping take the company public and eventually becoming CEO. He has over 20 years of experience in the industry, and has been at the forefront of driving innovation and efficiency in healthcare management.

Matthew Price, COO of Promontory Therapeutics is an experienced biotech entrepreneur / C-level executive, and the only company co-founder named a 2022 Emerging Pharma Leader by Pharmaceutical Executive. He is responsible for industry collaborations with Pfizer and Merck KGaA, and for Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute.

Robert Jacks, has 20 years of experience in the biopharmaceutical industry. He has founded or co-founded multiple companies and raised more than $170 million with several successful exits.

Dr. Marcelo Bigal, President and CEO of Ventus Therapeutics, a company that expects to become the leader in the field of using precision medicine to identify subsets of patients with severe chronic neurological conditions.

Monica Palko, Chief Legal & Administrative Officer of York Space Systems in Denver, Colorado. She provides strategic and operational guidance within the C-Suite, with responsibilities that include government and commercial contracting, legal and compliance, and corporate governance.

Kelly Hennig, Chief Operating Officer of Stoke Space, one of the fastest growing aerospace companies developing reusable rockets to provide the satellite industry with low-cost, on-demand access to and from any orbit. Stoke’s investors include NFX, MaC Ventures, YC, Seven Seven Six Ventures, and several others.

Molly Harper, Chief Business Officer of Synlogic, a biotechnology company that went public in 2017 through a reverse merger with Mirna Therapeutics raising an additional $40M after $100M in venture capital funding. Molly is also a member of the Board of Directors for Catalyst Pharmaceuticals and PreciseDX. Molly attended Wharton for her MBA, Healthcare Management, and Bachelor of Arts from Cornell University.

Vlad Vitoc is the Founder & CEO of MAIA, an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. Vlad and his team took MAIA public successfully in 2022 in one of the most difficult IPO markets in recent years.

Hans Keirstead, is a serial entrepreneur and currently the Founder, CEO and Chairman of Aivita Biomedical, a biotechnology company developing personalized vaccines for the prevention of infectious disease and treatment of cancer. He has now founded four biotechnology companies with successful exits in his previous three companies. Dr. Keirstead also holds Board positions in several prominent biotechnology companies.

Mani Mohindru, CEO of Novasenta has a non-traditional career path, starting as a scientist studying immune cells in the context of autoimmune diseases. She later worked in investment banking, which exposed her to different therapeutic areas, treatment modalities, and a full view of what a company can grow into. She then transitioned to the operations side of public biotechs as Chief Strategy Officer and eventually became a Chief Financial Officer before becoming the CEO of Novasena.

Brian Finrow is the CEO of Lumen Bioscience, where they are reinventing how biologic drugs are made. Unlike to a lot of Bioscience CEO’s, Brian comes from the legal industry having spent over 8 years at Cooley. Lumen's patented technology allows them to use the well-known food algae spirulina to deliver therapeutic proteins.

Ed Messman is the CEO of Rook Capital, a company that's on a mission to make home ownership and affordability more attainable for the next generation of home owners and real estate investors.

Joanne Mizell is the Chief Operating Officer of Banner|Aetna. Banner Health and Aetna created a joint venture to improve the health care system for members, for providers, and for employers alike through new synergies, new partners, and simplification.

Caleb Avery is the Founder & CEO of Tilled, a PayFac-as-a-Service company helping software companies monetize their payments. Tilled raised a Series of A of $11M in May of 2021 and raised another $11M in the beginning of 2022 as they quadrupled their team and tripled their valuation in just over 6 months.

Steve Lindsey, CTO & SVP Advanced Programs, Sierra Space

Monica Palko, Chief Legal & Administrative Officer, York Space Systems

Adam Harris, Chief Commercial Officer, Orbit Fab

Christine Spraker & Dr. Aki Alzubaidi are the Co-CEO's of Eon Health, a data science company that is on a mission to defy diseases by ensuring the right data reaches the right people at the right time. Eon Health is notably backed by Mark Cuban and recently raised a $16M series A led by Integrity Growth Partners.

Rob Carpenter is the Founder & CEO of Valyant AI which is on a mission to ease labor shortages through order automation. Valyant AI has built the world's first customer service AI designed for existing retail hardware such as drive through ordering machines. Prior to Valyant AI Rob was the CEO of AppIt Ventures, a software development company, and received his MBA from the University of Colorado with a specialization in Enterprise Technology Management.

Kevin McGarvey is the Founder & President of Hippo Health which is on a mission to easily connect patients and doctors through virtual care. Hippo Health has built a platform where you can talk, text, or video chat with a doctor when you need too. Prior to Hippo Health Kevin was the CEO of ErgentMD, an emergency physician, and has over 20 years of experience in healthcare startups.